ArticleJournal of neuroinflammation2014

Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.

Martin S Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.